TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients With Hepatocellular Carcinoma
Clinical trial NCT06114082 · COMPLETED
Trial details
- NCT number
- NCT06114082
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-28
- Primary completion
- 2026-07-01
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.